Gan PL, Huang S, Pan X, Xia HF, Zeng XY, Ren WS, Zhou X, Lv MH, Tang XW. Global research trends in the field of liver cirrhosis from 2011 to 2020: A visualised and bibliometric study. World J Gastroenterol 2022; 28(33): 4909-4919 [PMID: 36156929 DOI: 10.3748/wjg.v28.i33.4909]
Corresponding Author of This Article
Xiao-Wei Tang, MD, PhD, Doctor, Department of Gastroenterology, The Affiliated Hospital of Southwest Medical University, No. 25 Taiping Street, Jiangyang Region, Luzhou 646099, China. solitude5834@hotmail.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Scientometrics
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Pei-Ling Gan, Xiao Pan, Hui-Fang Xia, Xin-Yi Zeng, Wen-Sen Ren, Xian Zhou, Mu-Han Lv, Xiao-Wei Tang, Department of Gastroenterology, The Affiliated Hospital of Southwest Medical University, Luzhou 646099, Sichuan Province, China
Pei-Ling Gan, Xiao Pan, Hui-Fang Xia, Xin-Yi Zeng, Wen-Sen Ren, Xian Zhou, Mu-Han Lv, Xiao-Wei Tang, Department of Gastroenterology, Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou 646000, Sichuan Province, China
Shu Huang, Department of Gastroenterology, The People’s Hospital of Lianshui, Huaian 223400, Jiangsu Province, China
Author contributions: Gan PL, Huang S and Pan X contributed equally to this work; Gan PL, Zhou X, Lv MH and Tang XW designed the research study; Gan PL, Huang S, Pan X, Xia HF and Zeng XY performed the research; Pan X and Ren WS contributed analytic tools; Gan PL, Huang S and Pan X analyzed the data and wrote the manuscript; All authors have read and approve the final manuscript.
Conflict-of-interest statement: We declared that no conflicts of interest or financial ties to disclose.
PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Xiao-Wei Tang, MD, PhD, Doctor, Department of Gastroenterology, The Affiliated Hospital of Southwest Medical University, No. 25 Taiping Street, Jiangyang Region, Luzhou 646099, China. solitude5834@hotmail.com
Received: April 14, 2022 Peer-review started: April 14, 2022 First decision: June 10, 2022 Revised: June 17, 2022 Accepted: August 6, 2022 Article in press: August 6, 2022 Published online: September 7, 2022
ARTICLE HIGHLIGHTS
Research background
Liver cirrhosis is a common clinical chronic progressive disease with high mortality caused by one or more factors.
Research motivation
Identifying new trends in cirrhosis from 2011 to 2020, thus, providing new inspiration for scientific research.
Research objectives
This research intended to explore and analyse research trends and frontiers in this field of cirrhosis during the last 10 years.
Research methods
Using VOSviewer and CiteSpace, assess a discipline's evolution and identify frontier trends intuitively by knowledge maps.
Research results
The general research trend of liver cirrhosis has been growing, especially in China and the United States. The keywords “sofosbuvir,” “burden,” “care,” “sarcopenia,” “chronic liver failure,” “human gut microbiome,” and the “NAFLD” are expected to appear often in the following years, indicating emerging trends. The top five cirrhosis frontiers are Sarcopenia, Chronic liver failure, Sofosbuvir, Human gut microbiome and Nonalcoholic fatty liver disease.
Research conclusions
This study identified developing trends in the evolution of liver cirrhosis to provide new inspiration for researchers.
Research perspectives
The top five cirrhosis frontiers are sarcopenia, chronic liver failure, sofosbuvir, human gut microbiome and nonalcoholic fatty liver disease.
